glp-1 obesity drug market size 2025 Agonists Weight Loss Drugs Report, 2025-2030 The Global Obesity Therapeutics Market:

(2007) Incretin hormone mimetics and analogues in diabetes therapeutics

In a two-day study in healthy subjects, sitagliptin alone increased active GLP-1 concentrations, whereas metformin alone increased active and total GLP-1 concentrations to similar extents

Additionally, cAMP and PKA phosphorylate ERK1/2, which controls genes involved in proliferative and anti-apoptotic processes, and activate several proteins, such as the mitogen activated protein kinase (MAPK) cascades [63]

Puerarin ameliorates depressive symptoms in diabetic mice induced by high-fat diet

doi: 10.1038/s41591-021-01584-3 [DOI] [PubMed] [Google Scholar] 95

Salminen P, Kow L, Aminian A, et al